Trial · NCT04639193
Results by group48
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 48
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Apnea Hypopnea Index (AHI) | Dual-Therapy | AHI (supine, NREM) | 17.1 | Inter-Quartile Range 9.4 to 37.7 | events/hour of sleep |
| Apnea Hypopnea Index (AHI) | Placebo | AHI (supine, NREM) | 32.7 | Inter-Quartile Range 23.8 to 51.8 | events/hour of sleep |
| Apnea Hypopnea Index (AHI) | Triple-Therapy | AHI (supine, NREM) | 26 | Inter-Quartile Range 9.2 to 40 | events/hour of sleep |
| Apnea Hypopnea Index (AHI) | Dual-Therapy | AHI (overall) | 23.6 | Inter-Quartile Range 15.2 to 38.3 | events/hour of sleep |
| Apnea Hypopnea Index (AHI) | Placebo | AHI (overall) | 37.4 | Inter-Quartile Range 30.4 to 50 | events/hour of sleep |
| Apnea Hypopnea Index (AHI) | Triple-Therapy | AHI (overall) | 25.8 | Inter-Quartile Range 9.9 to 43.3 | events/hour of sleep |
| Apnea Hypopnea Index (AHI) | Dual-Therapy | AHI4 (overall) | 14.1 | Inter-Quartile Range 7.9 to 27.3 | events/hour of sleep |
| Apnea Hypopnea Index (AHI) | Placebo | AHI4 (overall) | 20.3 | Inter-Quartile Range 13.3 to 37.9 | events/hour of sleep |
| Apnea Hypopnea Index (AHI) | Triple-Therapy | AHI4 (overall) | 9 | Inter-Quartile Range 4.5 to 14.7 | events/hour of sleep |
| SpO2 Nadir | Dual-Therapy | 83.5 | Inter-Quartile Range 79.8 to 87.2 | Percent Oxygen Saturation | |
| SpO2 Nadir | Placebo | 84 | Inter-Quartile Range 82 to 85.2 | Percent Oxygen Saturation | |
| SpO2 Nadir | Triple-Therapy | 86 | Inter-Quartile Range 82.5 to 87.5 | Percent Oxygen Saturation | |
| Pathophysiological Traits: Vpassive, Vactive, Arousal Threshold | Dual-Therapy | Vpasssive, transformed | 69.5 | Inter-Quartile Range 58.7 to 78.2 | % Veupnea |
| Pathophysiological Traits: Vpassive, Vactive, Arousal Threshold | Placebo | Vpasssive, transformed | 67.4 | Inter-Quartile Range 59.4 to 73.2 | % Veupnea |
| Pathophysiological Traits: Vpassive, Vactive, Arousal Threshold | Triple-Therapy | Vpasssive, transformed | 70.4 | Inter-Quartile Range 61.7 to 75.3 | % Veupnea |
| Pathophysiological Traits: Vpassive, Vactive, Arousal Threshold | Dual-Therapy | Vactive | 96.2 | Inter-Quartile Range 79 to 99.1 | % Veupnea |
| Pathophysiological Traits: Vpassive, Vactive, Arousal Threshold | Placebo | Vactive | 92.1 | Inter-Quartile Range 83.9 to 97.7 | % Veupnea |
| Pathophysiological Traits: Vpassive, Vactive, Arousal Threshold | Triple-Therapy | Vactive | 94.4 | Inter-Quartile Range 83.9 to 99.6 | % Veupnea |
| Pathophysiological Traits: Vpassive, Vactive, Arousal Threshold | Dual-Therapy | Arousal Threshold, transformed | 140.1 | Inter-Quartile Range 126.7 to 161.5 | % Veupnea |
| Pathophysiological Traits: Vpassive, Vactive, Arousal Threshold | Placebo | Arousal Threshold, transformed | 149.8 | Inter-Quartile Range 137.9 to 162.2 | % Veupnea |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04639193/results